Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • canozdoruk
    Junior Member
    • Oct 2013
    • 2

    #1

    [Free Webinar] Introduction to SeqAn, an Open-source C++ Template Library

    On October 22nd join us for a webinar presented by Prof. Dr. Knut Reinert to learn how a team of scientist created a library for analysis of sequences with the focus on biological data. SeqAn applies a unique generic design that guarantees high performance, generality, extensibility, and integration with other libraries. SeqAn is easy to use and simplifies the development of new software tools with a minimal loss of performance.
    This webinar is planned for October 22nd 2013 at 9.00 AM Pacific Time.

    Register at: http://bit.ly/SeqAn

    About Prof. Dr. Knut Reinert
    Knut Reinert received his PhD from Max-Planck-Institute for Computer Science in Saarbrücken, Germany. Following this he joined Celera Genomics as a senior scientist. At Celera he worked in the group of Professor Gene Myers and participated in the assembly efforts for the genomes of Drosophila Melanogaster and human (see The Human Genome Project). Since 2002, Knut Reinert is a full professor at Freie Universität Berlin.
  • sisch
    Member
    • Jun 2011
    • 29

    #2
    If this is phishing, this is the first time of my life, I fell for it.
    If not, the registration form just does not work for me.
    (Returns Webinar not available)

    In any case, I would have loved to hear about that.

    UPDATE: Despite the error, I got a confirmation by mail, so everything's fine now
    Last edited by sisch; 10-10-2013, 04:35 AM.

    Comment

    • westerman
      Rick Westerman
      • Jun 2008
      • 1104

      #3
      I got signed up as well. Don't know if it will be any good but, heck, an webinar is only an hour out of my life.

      Comment

      • canozdoruk
        Junior Member
        • Oct 2013
        • 2

        #4
        Thanks guys. Be happy to host you next week.

        Comment

        Latest Articles

        Collapse

        • SEQadmin2
          Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
          by SEQadmin2



          CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

          Despite this, “CRISPR helped turn genome editing from a specialized technique into
          ...
          07-31-2026, 11:01 AM
        • SEQadmin2
          Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
          by SEQadmin2


          Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

          The systematic characterization of the human proteome has
          ...
          07-20-2026, 11:48 AM

        ad_right_rmr

        Collapse

        News

        Collapse

        Topics Statistics Last Post
        Started by SEQadmin2, 08-06-2026, 07:41 AM
        0 responses
        23 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 08-03-2026, 10:13 AM
        0 responses
        39 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-31-2026, 02:55 AM
        0 responses
        44 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-24-2026, 12:17 PM
        0 responses
        27 views
        0 reactions
        Last Post SEQadmin2  
        Working...